课题基金 / 基金详情

Identification and characterization of novel complexes controling chromatin structure

Identification and characterization of novel complexes controling chromatin structure
控制染色质结构的新型复合物的鉴定和表征
批准号:
16207009
负责人:
KATO Shigeaki
金额:
$28.79万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (A)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006

项目摘要

项目成果

KATO Shigeaki的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Gene expression is controlled through chromatin remodeling and histon modifications. Such chromatin structure rearrangement is conducted by a number of nuclear complexes composed of multiple subunits. In the present study, to identify and characterize the nuclear complexes to support hormone-induced transcriptional controls by nuclear receptors, a biochemical purification of complexes associating with sex steroid hormone receptors. By such biochemical screening, we could identify several complexes containing histone modifying enzymes. One of the complex was a novel complex containing histone acetyltransferase to coactivate estrogen receptor, while another complex was a histone deacetylase to corepress estrogen and androgen receptors. Moreover, we could identify a novel ubiquitin E3 ligase to degrate sex steroid receptor proteins. Previously, we had shown that activated dioxin receptor(AhR) by ligand binding coactivates unliganded sex steroid receptors in transcriptional controls through direct receptor-receptor protein interaction (Ohtake et al., Nature, 423, 545-550, 2003). However, transrepression of liganded steroid receptors by AhR was still under investigation. By biochemical purification of a complex containing AhR and sex steroid receptors, we have demonstrated that liganded AhR is ligand- dependent E3 ubiquitin ligase to degrate steroid receptors, thereby counteracting biological actions of sex steroid hormones (Ohtake et al., Nature, 446, 562-566, 2007).
期刊论文(21)
专著(0)
科研奖励(0)
会议论文
lalpha, 25(OH)2D3 -induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter.
lalpha, 25(OH)2D3 - 通过人甲状旁腺激素基因启动子中的 E-box 型元件诱导维生素 D 受体反式抑制。
DOI: --
发表时间: 2006
期刊: Mol. Endocrinol. 21
影响因子: --
作者: [Kim, M.-S., Fujiki, R., Murayama, A., Kitagawa, H., Yamamoto, K., Yamamoto, Y., Mihara, M., Takeyama, K., Kato, S.]
通讯作者: S.
Repressive domain of unliganded human estrogen receptor α associates with Hsc70
未配体的人雌激素受体 α 的抑制域与 Hsc70 相关
DOI: --
发表时间: 2005
期刊: Genes to Cells 10
影响因子: --
作者: [Ogawa, S., Oishi, H., Mezaki, Y., Kouzu-Fujita, M., Matsuyama, R., Nakagomi, M., Mori, E., Murayama, E., Nagasawa, H., Kitagawa, H., Yanagisawa.J., Kato, S.]
通讯作者: S.
lalpha, 25(OH)2D3 -induced transrepression by vitamin D receptor through E-box-type elements in the human parathyroid hormone gene promoter
lalpha, 25(OH)2D3 - 通过人甲状旁腺激素基因启动子中的 E-box 型元件诱导维生素 D 受体反式抑制
DOI: --
发表时间: 2006
期刊: MoL Endocrinol. 21
影响因子: --
作者: [Kim M.-S., Fujiki, R., Murayama, A., Kitagawa, H., Yamamoto, K., Yamamoto, Y., Mihara, M., Takeyama, K., Kato, S.]
通讯作者: S.
Transrepression by a liganded nuclear receptor via a bHLH activator through co-regulator switching
配体核受体通过 bHLH 激活剂通过共调节器切换进行反式抑制
DOI: --
发表时间: 2004
期刊: EMBO J. 23
影响因子: --
作者: [Murayama, A., Takeyama, K., Kato, S., et al.]
通讯作者: et al.
17
    The role of the nuclear receptors in cancer development
    • 批准号:
      17013023
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $30.46万
    • 财政年份:
      2005
    • 负责人:
      KATO Shigeaki
    • 依托单位:
    Mechanism of transcriptional regulation by nuclear receptors
    • 批准号:
      12219206
    • 项目类别:
      Grant-in-Aid for Scientific Research on Priority Areas
    • 资助金额:
      $80.06万
    • 财政年份:
      2000
    • 负责人:
      KATO Shigeaki
    • 依托单位:
    Search of novel nuclear orphan receptors for fat-soluble ligands
    Establishment of nuclear receptor-mediated assay for sex-steroid like compounds
    海外基金